GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mizuho Medy Co Ltd (TSE:4595) » Definitions » EPS (Diluted)

Mizuho Medy Co (TSE:4595) EPS (Diluted) : 円419.83 (TTM As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Mizuho Medy Co EPS (Diluted)?

Mizuho Medy Co's Earnings per Share (Diluted) for the three months ended in Mar. 2024 was 円101.93. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was 円419.83.

Mizuho Medy Co's EPS (Basic) for the three months ended in Mar. 2024 was 円101.93. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 was 円419.83.

Mizuho Medy Co's EPS without NRI for the three months ended in Mar. 2024 was 円101.93. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2024 was 円419.83.

During the past 12 months, Mizuho Medy Co's average EPS without NRIGrowth Rate was -40.00% per year. During the past 3 years, the average EPS without NRIGrowth Rate was 131.00% per year. During the past 5 years, the average EPS without NRI Growth Rate was 60.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 10 years, Mizuho Medy Co's highest 3-Year average EPS without NRI Growth Rate was 131.00% per year. The lowest was -22.60% per year. And the median was 28.10% per year.


Mizuho Medy Co EPS (Diluted) Historical Data

The historical data trend for Mizuho Medy Co's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mizuho Medy Co EPS (Diluted) Chart

Mizuho Medy Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EPS (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 91.80 32.16 505.73 822.94 396.27

Mizuho Medy Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 78.37 75.08 143.43 99.39 101.93

Competitive Comparison of Mizuho Medy Co's EPS (Diluted)

For the Drug Manufacturers - Specialty & Generic subindustry, Mizuho Medy Co's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mizuho Medy Co's PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mizuho Medy Co's PE Ratio distribution charts can be found below:

* The bar in red indicates where Mizuho Medy Co's PE Ratio falls into.



Mizuho Medy Co EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Mizuho Medy Co's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as

Diluted EPS (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(3774.239-0)/9.524
=396.29

Mizuho Medy Co's Diluted EPS for the quarter that ended in Mar. 2024 is calculated as

Diluted EPS (Q: Mar. 2024 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(970-0)/9.524
=101.85

EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円419.83

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mizuho Medy Co  (TSE:4595) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Mizuho Medy Co EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Mizuho Medy Co's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Mizuho Medy Co (TSE:4595) Business Description

Traded in Other Exchanges
N/A
Address
4 Fujinoki-Machi, Saga Prefecture, Tosu, JPN, 841-0048
Mizuho Medy Co Ltd engages in research and development, manufacture and distribution of in-vitro diagnostic products. The company provides immuno assay test products, such as influenza virus kits; Infectious diseases test kits; fecal occult blood test kits for detection of human hemoglobin and human transferrin in feces; and biochemical liquid stable reagents for professionals. It also offers HCG (midstream test), including digital p-check test for OTC. It also offers fruit tree virus test drugs to agricultural testing places.

Mizuho Medy Co (TSE:4595) Headlines

No Headlines